EDIT

#3022
Editas Medicine, Inc. Common Stock
2.20
+5.26%
Sector:
Base:
Profit Currency:
Daily Range
2.20
2.20
Year Range
0.91
4.54
Daily Change
+5.26%
Monthly Change
+3.29%
6 month change
-18.52%
Year Change
+22.91%
Previous Close
2.09
Open
2.20
Bid
Ask
Low
2.20
High
2.20
Volume
56
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024

Editas Medicine Inc

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

News